Search Within

James O'Brien

Formats
  1. Journal Article (20)
  2. Meeting Abstract (8)
Groups
  1. Department of Medicine (16)
  2. Center for Hematologic Malignancies (13)
  3. Hematologic Malignancies, Division of (13)
  4. Lymphoma (13)
  5. GSK Faculty (5)
  6. Radiation Oncology, Department of (5)

More Groups

People
  1. Carol Portlock (12)
  2. David Straus (10)
  3. Joseph Bertino (8)
  4. Andrew Zelenetz (6)
  5. Carlos Cordon-Cardo (6)
  6. Craig Moskowitz (5)

More People

Years
  1. 2003 (1)
  2. 2001 (1)
  3. 1999 (1)
  4. 1998 (1)
  5. 1997 (3)
  6. 1996 (3)

More Years

Publications
  1. Blood (6)
  2. Journal of Clinical Oncology (3)
  3. International Journal of Radiation Oncology, Biology, Physics (2)
  4. Journal of Nuclear Medicine (2)
  5. Annals of Oncology (1)
  6. Cancer (1)

More Publications

Publishers
  1. American Society of Hematology (6)
  2. American Society of Clinical Oncology (3)
  3. Elsevier Inc. (3)
  4. Society of Nuclear Medicine (2)
  5. Academic Press Inc., Elsevier Science (1)
  6. American Association for Cancer Research (1)

More Publishers

Results (28)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • CHOP with high dose cyclophosphamide consolidation versus CHOP alone as initial therapy for advanced stage, indolent non-Hodgkin's lymphomas
    Journal Article

    Pan, D.; Qin, J.; Farber, C.; O'Brien, J.; Filippa, D.; Portlock, C. S.
    Leukemia and Lymphoma (2003)

    Fulltext@MSK | Save
  • A 2-step comprehensive high-dose chemoradiotherapy second-line program for relapsed and refractory Hodgkin disease: Analysis by intent to treat and development of a prognostic model
    Journal Article

    Moskowitz, C. H.; Nimer, S. D.; Zelenetz, A. D.; Trippett, T.; Hedrick, E. E.; Filippa, D. A.; Louie, D.; Gonzales, M.; Walits, J.; Coady-Lyons, N.; more...
    Blood (2001)

    Fulltext@MSK | Save
  • Ifosfamide, carboplatin, and etoposide: A highly effective cytoreduction and peripheral-blood progenitor-cell mobilization regimen for transplant- eligible patients with non-Hodgkin's lymphoma
    Journal Article

    Moskowitz, C. H.; Bertino, J. R.; Glassman, J. R.; Hedrick, E. E.; Hunte, S.; Coady-Lyons, N.; Agus, D. B.; Goy, A.; Jurcic, J.; Noy, A.; more...
    Journal of Clinical Oncology (1999)

    Fulltext@MSK | Save
  • Granulocyte-colony stimulating factor (G-CSF) may improve disease outcome in elderly patients with large cell lymphoma (LCL) treated with chop
    Meeting Abstract

    Donnelly, G. B.; Glassman, J.; Long, C.; Torres, P.; Straus, D. J.; O'Brien, J. P.; Zelenetz, A. D.; Moskowitz, C. H.; Portlock, C. S.
    Blood (1998)

    Fulltext@MSK | Save
  • Ifosfamide (I), carboplatin (C) and etoposide (E) (ICE) cytoreduction followed by high dose chemoradiotherapy and ASCT for refractory and relapsed Hodgkin's disease (HD): An intent to treat study
    Meeting Abstract

    Moskowitz, C. H.; Nimer, S. D.; Portlock, C. S.; Straus, D. J.; Pearse, R.; O'Brien, J. P.; Berger, M.; Gardner, S.; Trippett, T. M.; Zelenetz, A. D.; more...
    Blood (1997)

    Fulltext@MSK | Save
  • An economic analysis of the NHL-15 protocol for diffuse aggressive lymphomas: The potential for substantially reducing cost by improving outcomes
    Meeting Abstract

    O'Brien, J. P.
    Blood (1997)

    Fulltext@MSK | Save
  • Primary mediastinal diffuse large cell lymphoma (PMLCL): Clinical characteristics and prognostic factors in 93 patients
    Meeting Abstract

    Hedrick, E. E.; O'Brien, J. P.; Glassman, J.; Straus, D. J.; Portlock, C. S.; Singer, A.; Zelenetz, A. D.; Moskowitz, C. H.
    Blood (1997)

    Fulltext@MSK | Save
  • Non-Hodgkin lymphoma: Contribution of chest CT in the initial staging evaluation
    Journal Article

    Castellino, R. A.; Hilton, S.; O'Brien, J. P.; Portlock, C. S.
    Radiology (1996)

    Fulltext@MSK | Save
  • Chemosensitive epidural spinal cord disease in non-Hodgkins lymphoma
    Journal Article

    Wong, E. T.; Portlock, C. S.; O'Brien, J. P.; DeAngelis, L. M.
    Neurology (1996)

    Fulltext@MSK | Save
  • CD30 (Ki-1)-positive malignant lymphomas: Clinical, immunophenotypic, histologie, and genetic characteristics and differences with Hodgkin's disease
    Journal Article

    Filippa, D. A.; Ladanyi, M.; Wollner, N.; Straus, D. J.; O'Brien, J. P.; Portlock, C.; Gangi, M.; Sun, M.
    Blood (1996)

    Fulltext@MSK | Save